【摘要】 自体造血干细胞移植是成人急性白血病缓解后的治疗方法之一，但在我国成人急性白血病患者治疗中应用较少。为提高临床医师对自体造血干细胞移植在成人急性白血病治疗中作用和地位的认识，中华医学会血液学分会造血干细胞应用学组参考国内外最新指南和文献，荟萃国内外最新研究成果，共同制定了《中国成人急性白血病自体造血干细胞移植专家共识(2024年版)》。文章拟对该共识重点部分进行解读，以期更好地指导临床实践。更多还原

【Abstract】 Autologous hematopoietic stem cell transplantation(auto-HSCT) represents a notable therapeutic modality for adult acute leukemia(AL) post-remission. Nonetheless, the utilization of auto-HSCT among adult AL patients in China currently remains limited. In a bid to bolster comprehension among clinicians regarding the pivotal role and significance of auto-HSCT in adult AL management, the Stem Cell Application Group of Chinese Society of Hematology have referred to the latest guidelines and literature both domestically and internationally, and have compiled the latest research findings from around the world to jointly formulate the "Chinese consensus on autologous hematopoietic stem cell transplantation for adult acute leukemia(2024)". To better guide clinical practice, this article intends to interpret the key parts of the consensus.更多还原